Digital Asset DirectProactive research analyst on Numinus Wellness' annual results
Numinus Wellness Inc.
Contact Details Proactive Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
December 19, 2022 08:02 AM Eastern Standard Time
Video
Digital Asset Direct
Digital Asset DirectSkinBioTherapeutics will "continue to be flexible enough to adapt to opportunities"
SkinBioTherapeutics PLC
Contact Details Proactive Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
December 19, 2022 06:14 AM Eastern Standard Time
Video
Digital Asset DirectProactive research analyst John Savin on Oxford Cannabinoid Technologies
Oxford Cannabinoid Technologies Holdings PLC
Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
December 15, 2022 07:30 AM Eastern Standard Time
Video
Digital Asset DirectPoolbeg Pharma makes "interesting addition to existing collaboration"
Poolbeg Pharma PLC
Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
December 15, 2022 04:48 AM Eastern Standard Time
Video
Digital Asset DirectOxford Cannabinoid Technologies "very confident" heading into 2023
Oxford Cannabinoid Technologies Holdings PLC
Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
December 15, 2022 04:36 AM Eastern Standard Time
Video
Digital Asset DirectKromek Group "delighted" with new contracts
Kromek Group PLC
Contact Details Proactive Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
December 15, 2022 04:30 AM Eastern Standard Time
Video
Digital Asset DirectFutura Medical "on track" for launch in H1 2023
Futura Medical PLC
Contact Details Proactive Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
December 13, 2022 08:08 AM Eastern Standard Time
Video
Digital Asset DirectSpectrumX Holdings ready for first in-human clinical trial
SpectrumX Holdings UK Ltd
Contact Details Proactive Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
December 13, 2022 04:33 AM Eastern Standard Time
Video
Digital Asset DirectPoolbeg Pharma receives initial results from human challenge clinical study
Poolbeg Pharma PLC
Contact Details Proactive UK Ltd +44 20 7989 0813 uk@proactiveinvestors.com
December 12, 2022 06:59 AM Eastern Standard Time
Video